W. Greenfield

Evaluation of DNA extraction protocols from liquid-based cytology specimens for studying cervical microbiota

T. Sasagawa, S. Owens, H. Coleman, 2020, bioRxiv.

Distribution of human papillomavirus (HPV) types and anti-HPV T-cell immune responses among different racial/ethnic groups in Central Arkansas.

H. Coleman, M. Nakagawa, W. Greenfield, 2013, The Journal of the Arkansas Medical Society.

Telemedicine collaboration improves perinatal regionalization and lowers statewide infant mortality

D. K. Williams, W. Greenfield, D. Kuo, 2013, Journal of Perinatology.

A Human Papillomavirus Type 16 E6 52-62 CD4 T-Cell Epitope Restricted by the HLA-DR11 Molecule Described in an Epitope Hotspot.

H. Coleman, M. Nakagawa, W. Greenfield, 2014, MOJ immunology.

Editorial Comment: Understanding Cost Variation in STD Service Delivery as State and Federal Agencies Reduce Funding

W. Greenfield, M. Preston, Sharla A Smith, 2014 .

Detection of Human Papillomavirus Type 16-Specific T Lymphocytes by a Recombinant Vaccinia Virus-Based Enzyme-Linked Immunospot Assay

M. Nakagawa, W. Greenfield, Kevin H Kim, 2007, Clinical and Vaccine Immunology.

Detection of Human Papillomavirus Type 16-Specific T Lymphocytes by a Recombinant Vaccinia Virus-Based Enzyme-Linked Immunospot Assay (cid:1)

M. Nakagawa, W. Greenfield, Kevin H Kim, 2007 .

Maternal and perinatal outcomes of indicated inductions of labor

S. Ounpraseuth, J. Morrison, E. Magann, 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Low-grade fibromyxoid sarcoma presenting clinically as a primary ovarian neoplasm: a case report.

J. McKenney, L. E. De Las Casas, W. Greenfield, 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

A Favorable Clinical Trend Is Associated With CD8 T-Cell Immune Responses to the Human Papillomavirus Type 16 E6 Antigens in Women Being Studied for Abnormal Pap Smear Results

H. Coleman, M. Nakagawa, W. Greenfield, 2010, Journal of lower genital tract disease.

Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination

L. Hutchins, H. Coleman, R. Edmondson, 2016, Cancer Immunology, Immunotherapy.

Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic Vaccines

H. Coleman, M. Nakagawa, W. Greenfield, 2015, Clinical and Vaccine Immunology.

CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend

H. Coleman, M. Nakagawa, W. Greenfield, 2011, Cancer Immunology, Immunotherapy.

A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3

L. Hutchins, H. Coleman, M. Nakagawa, 2015, Oncoimmunology.

Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion

H. Coleman, Kathryn Iverson, M. Robeson, 2019, Integrative cancer therapies.

A novel use of a statewide telecolposcopy network for recruitment of participants in a Phase I clinical trial of a human papillomavirus therapeutic vaccine

Horace J Spencer, M. Nakagawa, W. Greenfield, 2015, Clinical trials.